Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Brotchie

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Neuropharmacology|June 30, 2006
A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated ratsJoohyung Lee, Vincenzo Di Marzo, Jonathan M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Serotonin and Parkinson's disease: On movement, mood, and madnessSusan H Fox, Rosalind Chuang, Jonathan M Brotchie
Neuroscience Research|June 15, 2010
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolitesAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Journal of Molecular Neuroscience : MN|May 13, 2011
Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesiaAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Neuroscience Research|March 23, 2010
Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptorsAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Experimental Neurology|May 19, 2005
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidusKaterina Venderova, Timothy M Brown, Jonathan M Brotchie
Progress in Neurobiology|September 1, 2011
The serotonergic system in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Trends in Neurosciences|April 12, 2003
Presymptomatic compensation in Parkinson's disease is not dopamine-mediatedErwan Bezard, Christian E Gross, Jonathan M Brotchie
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Neuropharmacology|June 30, 2006
A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated ratsJoohyung Lee, Vincenzo Di Marzo, Jonathan M Brotchie
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Serotonin and Parkinson's disease: On movement, mood, and madnessSusan H Fox, Rosalind Chuang, Jonathan M Brotchie
Neuroscience Research|June 15, 2010
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolitesAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Journal of Molecular Neuroscience : MN|May 13, 2011
Changes in the mRNA levels of α2A and α2C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesiaAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Neuroscience Research|March 23, 2010
Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptorsAmal Alachkar, Jonathan M Brotchie, Owen T Jones
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Experimental Neurology|May 19, 2005
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidusKaterina Venderova, Timothy M Brown, Jonathan M Brotchie
Progress in Neurobiology|September 1, 2011
The serotonergic system in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Trends in Neurosciences|April 12, 2003
Presymptomatic compensation in Parkinson's disease is not dopamine-mediatedErwan Bezard, Christian E Gross, Jonathan M Brotchie
Pageof 13